CIK 0002124080 · <br>Emerging growth company
Aspen Neuroscience, Inc.
Sign in to watch- Ticker
- ASPE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- other
- EIN
- 831312969
- Phone
- 858.263.1222
- Business address
- 10835 ROAD TO THE CURE, SUITE 100, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $67,999,995
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$67,999,995. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Thompson Peter A. Director | Purchase | +1,000,000 | $15.00 | $15.0M | 3,589,132 |
| 2026-11-02 | ORBIMED ADVISORS LLC Director | Purchase | +1,000,000 | $15.00 | $15.0M | 3,589,132 |
| 2026-11-02 | ARCH Venture Fund X, L.P. 10% owner | Purchase | +66,666 | $15.00 | $1000K | 66,666 |
| 2026-11-02 | ARCH Venture Fund X, L.P. 10% owner | Purchase | +66,667 | $15.00 | $1.0M | 66,667 |
| 2026-11-02 | ARCH Venture Fund X, L.P. 10% owner | Purchase | +1,200,000 | $15.00 | $18.0M | 1,200,000 |
| 2026-11-02 | ARCH Venture Partners XIV, L.P. 10% owner | Purchase | +1,200,000 | $15.00 | $18.0M | 1,200,000 |
Page 1 of 1 · 6 trades